Record #:

26186

Author(s):

Stock, Christina S.

Abstract:

UNC researchers at the Cystic Fibrosis Center are developing a drug treatment that may curtail deteriorative lung disease, the primary cause of premature death in cystic fibrosis patients. The drug fights against lung malfunctions by hydrating the airways and reducing the absorptive process.

Source:

Endeavors (NoCar LD 3941.3 A3), Vol. 10 Issue 1, Fall 1992, p10-11, il, por

Subject(s):

University of North Carolina at Chapel Hill--Research